Volume 69 Received 14 February 2013 | ||||||||||
| ||||||||||
aApplied Organic Chemistry Department, National Research Centre, Dokki, 12622 Giza, Egypt,bDepartment of Chemistry, Faculty of Science, Mansoura University, ET-35516 Mansoura, Egypt,cDepartment of Chemistry, University of Malaya, 50603 Kuala Lumpur, Malaysia, and dChemistry Department, Faculty of Science, King Abdulaziz University, PO Box 80203 Jeddah, Saudi Arabia
Correspondence e-mail: edward.tiekink@gmail.com
In the title compound, C16H13ClFN3S, the pyrazole ring adopts an envelope conformation with the methine C atom being the flap atom. The chloro- and fluorobenzene rings are twisted out of the plane of the pyrazole ring [dihedral angles = 15.12 (11) and 80.55 (10)°, respectively]. The amine group is orientated towards a ring N atom, forming an intramolecular N-H
N hydrogen bond. This H atom also forms a hydrogen bond to the F atom, which along with N-H
S hydrogen bonding leads to a supramolecular chain along the c axis. Connections between chains of the type Cl
lead to a layer in the bc plane.
For the biological activity of pyrazolin-1-ylthiazoles, see: Abdel-Wahab et al. (2009
, 2012
); Chimenti et al. (2010
). For related structures, see: Chantrapromma et al. (2012
); Abdel-Wahab et al. (2013
).
|
|
|
Data collection: CrysAlis PRO (Agilent, 2011
); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012
) and DIAMOND (Brandenburg, 2006
); software used to prepare material for publication: publCIF (Westrip, 2010
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HG5293 ).
We thank the Ministry of Higher Education (Malaysia) for funding structural studies through the High-Impact Research scheme (UM.C/HIR-MOHE/SC/12).
Abdel-Wahab, B. F., Abdel-Aziz, H. A. & Ahmed, E. M. (2009). Eur. J. Med. Chem. 44, 2632-2635.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Abdel-Wahab, B. F., Abdel-Latif, E., Mohamed, H. A. & Awad, G. E. A. (2012). Eur. J. Med. Chem. 52, 263-268.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Abdel-Wahab, B. F., Mohamed, H. A., Khidre, R. E., Ng, S. W. & Tiekink, E. R. T. (2013). Acta Cryst. E69, o386.
Agilent (2011). CrysAlis PRO. Agilent Technologies, Yarnton, England.
Brandenburg, K. (2006). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Chantrapromma, S., Nonthason, P., Suwunwong, T. & Fun, H.-K. (2012). Acta Cryst. E68, o830-o831.
![[details]](../../../../../../e/graphics/details.gif)
Chimenti, F., Carradori, S., Secci, D., Bolasco, A., Bizzarri, B., Chimenti, P., Granese, A., Yáñez, M. & Orallo, F. (2010). Eur. J. Med. Chem. 45, 800-804.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
![[details]](../../../../../../j/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.
![[details]](../../../../../../j/graphics/details.gif)